品牌 | 货号 | 包装单位 | 货期 | CAS | 产品名称 | 质量规格 | 单价(¥) | 购买数量 |
---|---|---|---|---|---|---|---|---|
毕得 | BD17611-1g | 1g | 现货 | 113975-31-8 |
N-(3-碘吡啶-2-基)棕榈酰胺 N-(3-Iodopyridin-2-yl)pivala... |
97% |
|
|
乐研 | 1017384-1g | 1g | 现货 | 113975-31-8 |
N-(3-碘吡啶-2-基)棕榈酰胺 N-(3-Iodopyridin-2-yl)pivala... |
98% |
|
|
乐研 | 1017384-5g | 5g | 现货 | 113975-31-8 |
N-(3-碘吡啶-2-基)棕榈酰胺 N-(3-Iodopyridin-2-yl)pivala... |
98% |
|
|
乐研 | 1017384-10g | 10g | 现货 | 113975-31-8 |
N-(3-碘吡啶-2-基)棕榈酰胺 N-(3-Iodopyridin-2-yl)pivala... |
98% |
|
|
乐研 | 1017384-25g | 25g | 现货 | 113975-31-8 |
N-(3-碘吡啶-2-基)棕榈酰胺 N-(3-Iodopyridin-2-yl)pivala... |
98% |
|
|
乐研 | 1017384-100g | 100g | 现货 | 113975-31-8 |
N-(3-碘吡啶-2-基)棕榈酰胺 N-(3-Iodopyridin-2-yl)pivala... |
98% |
|
|
罗恩 | R022793-1g | 1g | 5~7个工作日 | 113975-31-8 |
N-(3-碘吡啶-2-基)棕榈酰胺 3-Iodo-2-(2,2,2-trimethylace... |
97% |
|
|
罗恩 | R022793-5g | 5g | 5~7个工作日 | 113975-31-8 |
N-(3-碘吡啶-2-基)棕榈酰胺 3-Iodo-2-(2,2,2-trimethylace... |
97% |
|
|
罗恩 | R022793-10g | 10g | 5~7个工作日 | 113975-31-8 |
N-(3-碘吡啶-2-基)棕榈酰胺 3-Iodo-2-(2,2,2-trimethylace... |
97% |
|
|
罗恩 | R022793-25g | 25g | 5~7个工作日 | 113975-31-8 |
N-(3-碘吡啶-2-基)棕榈酰胺 3-Iodo-2-(2,2,2-trimethylace... |
97% |
|
|
麦克林2025 | N897394-1g | 1g | 7个工作日 | 113975-31-8 |
N-(3-碘吡啶-2-基)棕榈酰胺 N-(3-Iodopyridin-2-yl)pivala... |
97% |
|
|
麦克林2025 | N897394-5g | 5g | 7个工作日 | 113975-31-8 |
N-(3-碘吡啶-2-基)棕榈酰胺 N-(3-Iodopyridin-2-yl)pivala... |
97% |
|
|
麦克林2025 | N897394-10g | 10g | 7个工作日 | 113975-31-8 |
N-(3-碘吡啶-2-基)棕榈酰胺 N-(3-Iodopyridin-2-yl)pivala... |
97% |
|
|
麦克林2025 | N897394-25g | 25g | 7个工作日 | 113975-31-8 |
N-(3-碘吡啶-2-基)棕榈酰胺 N-(3-Iodopyridin-2-yl)pivala... |
97% |
|
|
源叶 | S79770-250mg | 250mg | 期货,请咨询 | 113975-31-8 |
N-(3-碘吡啶-2-基)棕榈酰胺 3-Iodo-2-(2,2,2-Trimethylace... |
98% |
|
|
源叶 | S79770-1g | 1g | 期货,请咨询 | 113975-31-8 |
N-(3-碘吡啶-2-基)棕榈酰胺 3-Iodo-2-(2,2,2-Trimethylace... |
98% |
|
|
源叶 | S79770-5g | 5g | 期货,请咨询 | 113975-31-8 |
N-(3-碘吡啶-2-基)棕榈酰胺 3-Iodo-2-(2,2,2-Trimethylace... |
98% |
|
|
源叶 | S79770-25g | 25g | 期货,请咨询 | 113975-31-8 |
N-(3-碘吡啶-2-基)棕榈酰胺 3-Iodo-2-(2,2,2-Trimethylace... |
98% |
|
|